UPR - Ticker AI Digest

Uniphar Group PLC 📰 1
TradingFloor AI GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Uniphar Group PLC in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, crunch, and the deeper desks.
UPR Data 2026-03-17 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (UPR) 1
UPR 14:36
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
UPR 06:01
Uniphar Group PLC
2025 Preliminary Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Uniphar PLCs 2025 Preliminary Results:**
Uniphar PLC, an international healthcare services company, reported strong financial results for 2025, highlighting significant growth across key metrics. The company achieved
**Organic Gross Profit Growth** 8.9%, the fastest rate since its IPO, driven by strong performance in all divisions, particularly Pharma (15.5%) and Medtech (10.5%).
**Adjusted EPS Growth** 21%, reaching 24.8 cents, supported by lower finance costs and a €35 million share buyback program.
**Revenue Growth** 11.0% to €3.1 billion, with constant currency growth at 11.1%.
**EBITDA Growth** 6.0% to €130.9 million, with organic growth at 9.0%.
**Net Bank Debt** Increased to €171.1 million, with leverage at 1.6x.
**Dividend** Total dividend of €5.2 million, representing a 5.2% per share increase year-on-year.
**Strategic Highlights**
Completed a €35 million share buyback program, repurchasing 13.4 million shares.
Acquired TouchStore to enhance digital and technology offerings in the pharmacy sector.
Progressed key strategic investments, including a new high-tech distribution facility in Ireland, scheduled for phased operation in mid-2026.
Maintained strong ESG ratings, including MSCI AAA and CDP B for the fourth consecutive year.
**Outlook**
Uniphar expects continued strong organic Gross Profit growth in line with its medium-term guidance. The company remains on track to achieve its target of €200 million EBITDA by 2028, with at least 80% of growth expected to be organic.
**CEO Comment**
Ger Rabbette, CEO, expressed satisfaction with the results, highlighting the fastest organic Gross Profit growth since IPO and strong Adjusted EPS growth. He reaffirmed confidence in achieving the 2028 EBITDA target.
**Financial Summary**
**Gross Profit** Increased 7.0% to €457.7 million, with a margin of 14.9%.
**Operating Profit** Decreased 6.2% to €76.9 million due to exceptional items.
**Profit Before Tax (Excluding Exceptionals):** Grew 17.4% to €71.8 million.
**Free Cash Flow Conversion** 99.1%, supported by favorable working capital movements.
**Divisional Performance**
**Uniphar Pharma** 15.5% organic Gross Profit growth, driven by Global Sourcing and clinical trial supply.
**Uniphar Medtech** 10.5% organic Gross Profit growth, supported by geographic expansion and new supplier rollouts.
**Uniphar Supply Chain & Retail** 4.2% organic Gross Profit growth, with strong volume growth in Supply Chain.
**Balance Sheet and Liquidity**
Robust balance sheet with net bank debt of €171.1 million and leverage at 1.6x.
Extended revolving credit facility maturity to August 2029 and placed a new €150 million term loan.
**Sustainability**
Reduced Scope 1 and 2 emissions by 29.9% since 2019.
Continued progress on Science-Based Targets and strong ESG ratings.
**Analyst Presentation**
A conference call for analysts and investors was scheduled for February 24, 2026, with details available on the company’s website.
**Conclusion**
Uniphar PLC delivered a strong performance in 2025, with significant growth across key financial metrics and strategic advancements. The company remains well-positioned for future growth, supported by its diversified healthcare services portfolio and strategic investments.
Here is the HTML table code comparing the financials and debt year on year for Uniphar PLC:
Metric2025 (€'000)2024 (€'000)Change
Revenue3,074,7042,770,42911.0%
Gross Profit457,692427,6047.0%
EBITDA130,909123,4586.0%
Operating Profit76,87581,989(6.2%)
Profit before tax71,79561,13017.4%
Net bank debt(171,139)(147,676)(15.9%)
Basic EPS (cent)19.523.5(17.0%)
Adjusted EPS (cent)24.820.521.0%
Leverage (times)1.551.475.4%

Key Observations:

  • Revenue increased by 11.0% from 2024 to 2025, driven by strong volume growth across all divisions.
  • Gross Profit grew by 7.0%, with organic growth of 8.9%, the fastest rate since IPO.
  • EBITDA increased by 6.0%, with organic EBITDA growth of 9.0%.
  • Net bank debt increased by 15.9%, resulting in a higher leverage ratio of 1.55 times in 2025 compared to 1.47 times in 2024.
  • Adjusted EPS grew by 21.0%, reflecting strong business performance and the positive impact of lower finance costs and share buybacks.
This table provides a clear comparison of key financial metrics and debt between 2024 and 2025 for Uniphar PLC. The observations highlight the company's strong revenue and profit growth, as well as the increase in debt and leverage ratio.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 5
UPR 14:36
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 11:00
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 12:31
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 13:46
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 13:46
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 6
UPR 14:36
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 11:00
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 12:31
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 13:46
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 13:46
Uniphar Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
UPR 06:01
Uniphar Group PLC
2025 Preliminary Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Uniphar PLCs 2025 Preliminary Results:**
Uniphar PLC, an international healthcare services company, reported strong financial results for 2025, highlighting significant growth across key metrics. The company achieved
**Organic Gross Profit Growth** 8.9%, the fastest rate since its IPO, driven by strong performance in all divisions, particularly Pharma (15.5%) and Medtech (10.5%).
**Adjusted EPS Growth** 21%, reaching 24.8 cents, supported by lower finance costs and a €35 million share buyback program.
**Revenue Growth** 11.0% to €3.1 billion, with constant currency growth at 11.1%.
**EBITDA Growth** 6.0% to €130.9 million, with organic growth at 9.0%.
**Net Bank Debt** Increased to €171.1 million, with leverage at 1.6x.
**Dividend** Total dividend of €5.2 million, representing a 5.2% per share increase year-on-year.
**Strategic Highlights**
Completed a €35 million share buyback program, repurchasing 13.4 million shares.
Acquired TouchStore to enhance digital and technology offerings in the pharmacy sector.
Progressed key strategic investments, including a new high-tech distribution facility in Ireland, scheduled for phased operation in mid-2026.
Maintained strong ESG ratings, including MSCI AAA and CDP B for the fourth consecutive year.
**Outlook**
Uniphar expects continued strong organic Gross Profit growth in line with its medium-term guidance. The company remains on track to achieve its target of €200 million EBITDA by 2028, with at least 80% of growth expected to be organic.
**CEO Comment**
Ger Rabbette, CEO, expressed satisfaction with the results, highlighting the fastest organic Gross Profit growth since IPO and strong Adjusted EPS growth. He reaffirmed confidence in achieving the 2028 EBITDA target.
**Financial Summary**
**Gross Profit** Increased 7.0% to €457.7 million, with a margin of 14.9%.
**Operating Profit** Decreased 6.2% to €76.9 million due to exceptional items.
**Profit Before Tax (Excluding Exceptionals):** Grew 17.4% to €71.8 million.
**Free Cash Flow Conversion** 99.1%, supported by favorable working capital movements.
**Divisional Performance**
**Uniphar Pharma** 15.5% organic Gross Profit growth, driven by Global Sourcing and clinical trial supply.
**Uniphar Medtech** 10.5% organic Gross Profit growth, supported by geographic expansion and new supplier rollouts.
**Uniphar Supply Chain & Retail** 4.2% organic Gross Profit growth, with strong volume growth in Supply Chain.
**Balance Sheet and Liquidity**
Robust balance sheet with net bank debt of €171.1 million and leverage at 1.6x.
Extended revolving credit facility maturity to August 2029 and placed a new €150 million term loan.
**Sustainability**
Reduced Scope 1 and 2 emissions by 29.9% since 2019.
Continued progress on Science-Based Targets and strong ESG ratings.
**Analyst Presentation**
A conference call for analysts and investors was scheduled for February 24, 2026, with details available on the company’s website.
**Conclusion**
Uniphar PLC delivered a strong performance in 2025, with significant growth across key financial metrics and strategic advancements. The company remains well-positioned for future growth, supported by its diversified healthcare services portfolio and strategic investments.
Here is the HTML table code comparing the financials and debt year on year for Uniphar PLC:
Metric2025 (€'000)2024 (€'000)Change
Revenue3,074,7042,770,42911.0%
Gross Profit457,692427,6047.0%
EBITDA130,909123,4586.0%
Operating Profit76,87581,989(6.2%)
Profit before tax71,79561,13017.4%
Net bank debt(171,139)(147,676)(15.9%)
Basic EPS (cent)19.523.5(17.0%)
Adjusted EPS (cent)24.820.521.0%
Leverage (times)1.551.475.4%

Key Observations:

  • Revenue increased by 11.0% from 2024 to 2025, driven by strong volume growth across all divisions.
  • Gross Profit grew by 7.0%, with organic growth of 8.9%, the fastest rate since IPO.
  • EBITDA increased by 6.0%, with organic EBITDA growth of 9.0%.
  • Net bank debt increased by 15.9%, resulting in a higher leverage ratio of 1.55 times in 2025 compared to 1.47 times in 2024.
  • Adjusted EPS grew by 21.0%, reflecting strong business performance and the positive impact of lower finance costs and share buybacks.
This table provides a clear comparison of key financial metrics and debt between 2024 and 2025 for Uniphar PLC. The observations highlight the company's strong revenue and profit growth, as well as the increase in debt and leverage ratio.

AI Crunch

Single-Ticker AI Crunch
UPR signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Uniphar Group PLC. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full UPR AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for UPR on 2026-03-17.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
946.3M
Enterprise Value
991.3M
Public Float
90.0
Broker Target
397.9495
Shares Out
259.6M
Long Interest
95
Short Interest
5
Exchange
LSE
Currency Code
GBX
ISIN
IE00BJ5FQX74
Market
LSE - AIM
Sector
Personal Care, Drug and Grocery Stores
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for UPR.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2026-03-17 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Uniphar Group PLC has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.02
Ex Divi
2026-04-23
Earnings Date
2026-02-23
Net Debt
463.9M
Cash
183.9M
EPS
0.17
Net Income
51.1M
Revenue
3.1B
Enterprise Value
991.3M
Trailing PE
20.8824
Forward PE
16.6389
Price Sales TTM
0.3078
Price Book MRQ
2.6123
EV Revenue
0.4599
EV EBITDA
11.7987
Financial Forecastist

Improving financial engine

Revenue is accelerating +132.3% against the prior comparable period. Net margin is expanding by 1.0 pts. Net debt is building +222.6%.

Revenue +132.3% Net Income +337.2% FCF +268.5% Current Ratio 0.99x Forward Rev 0
Improving
Quarter Revenue
1.6B
+132.3%
vs prior comparable quarter
Net Margin
+2.1%
+1.0 pts
profitability pulse
Free Cash Flow
75.8M
+268.5%
cash conversion
Net Debt / EBITDA
6.5x
+222.6%
lower is cleaner
Revenue Engine

Latest quarter printed 1.6B with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 33.6M and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 183.9M while net debt is 463.9M. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2026
Consensus
3.2B
Revenue Path
0.25
EPS / Earnings
Growth cue +0.0%
FY 2027
Consensus
3.4B
Revenue Path
0.27
EPS / Earnings
Growth cue +0.1%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q4 2025 1.6B 33.6M 75.8M 463.9M
Q2 2025 1.5B 17.5M 9.1M 355.7M
Q4 2024 1.4B 48.8M 3.4M 303.2M
Q2 2024 1.4B 15.3M 41.1M 322.2M
Q1 2024 683.8M 7.7M 20.6M 143.8M
Q4 2023 1.3B 29.7M 47.4M 296.3M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 3.1B 51.1M 126.8M 84.9M
FY 2024 2.8B 64.2M 136.4M 22.2M
FY 2023 2.6B 44.8M 112.9M 20.6M
FY 2022 2.1B 45.6M 92.4M 62.9M
FY 2021 1.9B 48.1M 89.7M 37.7M

Structure DNA

Market Structure DNA

Yield Compounder profile with trend runway open

Price is 97.6% through the 52-week range, +5.8% vs 50DMA and +9.2% vs 200DMA. 52.0% of the register is locked by institutions and insiders, leaving 48.0% free float. Capital rhythm reads semi-annual with forward yield near 0.5% and payout around 4.1%.

Trend runway open Institutional gravity Reliable income rhythm As Of 2026-04-19
Yield Compounder
Structure Score
74.5 / 100
Yield Compounder
Trend Stack
+5.8% / +9.2%
vs 50DMA / 200DMA
52W Position
97.6%
auction position inside the yearly range
Ownership Lock
52.0%
46.9% institutions | 5.1% insiders
Pressure Pocket
48.0% free float
Vendor short-float fields were not supplied
Capital Rhythm
Semi-Annual
Yield 0.5% | payout 4.1%
Trend Runway

Implied spot is 364.56 with the stock +5.8% vs 50DMA and +9.2% vs 200DMA. The tape is sitting 97.6% through the 52-week range, which frames the regime as trend runway open.

Ownership Register

Institutions hold about 46.9% and insiders about 5.1%, locking roughly 52.0% of the register and leaving 48.0% in free float. That reads as institutional gravity.

Pressure Pocket

The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.

Capital Rhythm

Dividend cadence reads semi-annual with 2 event(s) in the last full year, a five-year average of 2.0, and stability score 100.0/100. Forward yield sits near 0.5% while payout is around 4.1%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Semi-Annual
Year Dividend Count Context
2025 2 Full year
2024 2 Full year
2023 2 Full year
2022 2 Full year
2021 2 Full year
2020 1 Full year

Structure Facts

Live Snapshot
Implied Spot
364.56
derived from market cap / shares
52W High
368.00
upper auction edge
52W Low
224.56
lower auction edge
Beta
1.14
volatility character
Shares Out
259.6M
fully diluted count
Shares Float
233.8M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
2026-04-23
4 day(s) to ex-date
Dividend Pay
-
payment date not supplied
Last Split
1:100
2021-02-01

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
14.4387
Institutions As Of
2026-04-07
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
5
Sale Director Dealing
3
Purchase TR1
7
Sale TR1
5
Broker Coverage Rows
2
Institution Holders Tracked
3
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for UPR, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2026-03-17 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Uniphar Group PLC has fresh news flow live now, so the tape is framing the chart workspace below.
AI Charts Studio
UPR Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-03-17 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 1.51%
RSI Gauge
Price Change
AI Forecast